Grace Therapeutics Stock Performance

GRCE Stock   3.48  0.20  5.43%   
On a scale of 0 to 100, Grace Therapeutics holds a performance score of 9. The company retains a Market Volatility (i.e., Beta) of 0.0024, which attests to not very significant fluctuations relative to the market. As returns on the market increase, Grace Therapeutics' returns are expected to increase less than the market. However, during the bear market, the loss of holding Grace Therapeutics is expected to be smaller as well. Please check Grace Therapeutics' sortino ratio, semi variance, and the relationship between the information ratio and value at risk , to make a quick decision on whether Grace Therapeutics' current trending patterns will revert.

Risk-Adjusted Performance

Good

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Grace Therapeutics are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of rather unsteady fundamental indicators, Grace Therapeutics exhibited solid returns over the last few months and may actually be approaching a breakup point. ...more

Actual Historical Performance (%)

One Day Return
(0.81)
Five Day Return
3.95
Year To Date Return
0.55
Ten Year Return
22.26
All Time Return
22.26
Last Split Factor
1:6
Last Split Date
2023-07-10
1
Grace Therapeutics to Participate in 16th Annual Craig-Hallum Alpha Select Conference
11/17/2025
2
Vanco and ACS Technologies Unite to Deliver More Connected Services and Solutions for Churches
12/03/2025
3
Acasti Pharma Shares Up 1.8 percent Still a Buy
12/16/2025
4
Grace Therapeutics, Inc. Sees Large Growth in Short Interest
12/31/2025
5
How Grace Therapeutics Inc. stock compares to growth peers - Walking Comfort Picks HOKA model picks for your routine - ulpravda.ru
01/09/2026
6
Acquisition by Kottayil George of 10000 shares of Grace Therapeutics at 3.8 subject to Rule 16b-3
01/12/2026
7
Aug Fed Impact Why is Grace Therapeutics Inc stock going up - Market Trend Review Smart Allocation Stock Tips - baoquankhu1.vn
02/02/2026

Grace Therapeutics Relative Risk vs. Return Landscape

If you would invest  299.00  in Grace Therapeutics on November 7, 2025 and sell it today you would earn a total of  49.00  from holding Grace Therapeutics or generate 16.39% return on investment over 90 days. Grace Therapeutics is currently generating 0.2769% in daily expected returns and assumes 2.3809% risk (volatility on return distribution) over the 90 days horizon. In different words, 21% of stocks are less volatile than Grace, and 95% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.
  Expected Return   
       Risk  
Given the investment horizon of 90 days Grace Therapeutics is expected to generate 3.11 times more return on investment than the market. However, the company is 3.11 times more volatile than its market benchmark. It trades about 0.12 of its potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.09 per unit of risk.

Grace Therapeutics Target Price Odds to finish over Current Price

The tendency of Grace Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move above the current price in 90 days
 3.48 90 days 3.48 
about 34.46
Based on a normal probability distribution, the odds of Grace Therapeutics to move above the current price in 90 days from now is about 34.46 (This Grace Therapeutics probability density function shows the probability of Grace Stock to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days Grace Therapeutics has a beta of 0.0024. This usually indicates as returns on the market go up, Grace Therapeutics average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Grace Therapeutics will be expected to be much smaller as well. Additionally Grace Therapeutics has an alpha of 0.2314, implying that it can generate a 0.23 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta).
   Grace Therapeutics Price Density   
       Price  

Predictive Modules for Grace Therapeutics

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Grace Therapeutics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Grace Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
1.413.695.97
Details
Intrinsic
Valuation
LowRealHigh
3.685.968.24
Details
Naive
Forecast
LowNextHigh
1.353.635.91
Details
2 Analysts
Consensus
LowTargetHigh
11.0012.0913.42
Details

Grace Therapeutics Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Grace Therapeutics is not an exception. The market had few large corrections towards the Grace Therapeutics' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Grace Therapeutics, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Grace Therapeutics within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
0.23
β
Beta against Dow Jones0
σ
Overall volatility
0.25
Ir
Information ratio 0.08

Grace Therapeutics Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Grace Therapeutics for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Grace Therapeutics can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Grace Therapeutics has high likelihood to experience some financial distress in the next 2 years
Net Loss for the year was (9.57 M) with profit before overhead, payroll, taxes, and interest of 0.
Grace Therapeutics generates negative cash flow from operations
Grace Therapeutics has a frail financial position based on the latest SEC disclosures
About 27.0% of the company shares are held by company insiders
Latest headline from news.google.com: Aug Fed Impact Why is Grace Therapeutics Inc stock going up - Market Trend Review Smart Allocation Stock Tips - baoquankhu1.vn

Grace Therapeutics Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Grace Stock often depends not only on the future outlook of the current and potential Grace Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Grace Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding12.1 M
Cash And Short Term Investments22.1 M

Grace Therapeutics Fundamentals Growth

Grace Stock prices reflect investors' perceptions of the future prospects and financial health of Grace Therapeutics, and Grace Therapeutics fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Grace Stock performance.

About Grace Therapeutics Performance

By analyzing Grace Therapeutics' fundamental ratios, stakeholders can gain valuable insights into Grace Therapeutics' financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Grace Therapeutics has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Grace Therapeutics has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Last ReportedProjected for Next Year
Days Of Inventory On Hand49.6 K52 K
Return On Tangible Assets(0.48)(0.51)
Return On Capital Employed(0.21)(0.22)
Return On Assets(0.15)(0.16)
Return On Equity(0.14)(0.17)

Things to note about Grace Therapeutics performance evaluation

Checking the ongoing alerts about Grace Therapeutics for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Grace Therapeutics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Grace Therapeutics has high likelihood to experience some financial distress in the next 2 years
Net Loss for the year was (9.57 M) with profit before overhead, payroll, taxes, and interest of 0.
Grace Therapeutics generates negative cash flow from operations
Grace Therapeutics has a frail financial position based on the latest SEC disclosures
About 27.0% of the company shares are held by company insiders
Latest headline from news.google.com: Aug Fed Impact Why is Grace Therapeutics Inc stock going up - Market Trend Review Smart Allocation Stock Tips - baoquankhu1.vn
Evaluating Grace Therapeutics' performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Grace Therapeutics' stock performance include:
  • Analyzing Grace Therapeutics' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Grace Therapeutics' stock is overvalued or undervalued compared to its peers.
  • Examining Grace Therapeutics' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating Grace Therapeutics' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Grace Therapeutics' management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of Grace Therapeutics' stock. These opinions can provide insight into Grace Therapeutics' potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Grace Therapeutics' stock performance is not an exact science, and many factors can impact Grace Therapeutics' stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.

Complementary Tools for Grace Stock analysis

When running Grace Therapeutics' price analysis, check to measure Grace Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Grace Therapeutics is operating at the current time. Most of Grace Therapeutics' value examination focuses on studying past and present price action to predict the probability of Grace Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Grace Therapeutics' price. Additionally, you may evaluate how the addition of Grace Therapeutics to your portfolios can decrease your overall portfolio volatility.
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
CEOs Directory
Screen CEOs from public companies around the world
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Equity Valuation
Check real value of public entities based on technical and fundamental data